Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 68

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 5
Chunk 68
---

Management believes inflation has not had a material impact on our company’s operations or financial condition and that our operations are not currently subject to seasonal influences.
Conditions in Australia

We are incorporated under the laws of, and our principal offices and research and development facilities are located in, the Commonwealth of Australia. Therefore, we are directly affected by political and economic conditions in Australia. See Item 3.D. “Key Information – Risk Factors – Risks Relating to Our Location in Australia” for a description of factors that could materially affect our operations.
Recently Issued International Accounting Standards and Pronouncements

New and amended Accounting Standards and Interpretations issued and effective

There were no new or amended standards adopted by the Group in the year ended June 30, 2025 that materially impacted the Group. These financial statements follow the same accounting policies as used in the June 30, 2024 consolidated financial statements and related notes as filed with the Australian Securities Exchange and the Securities and Exchange Commission.
Australian Disclosure Requirements

Dividends

No dividends have been paid during the financial year (2025: nil). The Directors do not recommend the payment of a dividend in respect of the current financial year (2024: nil).

Significant changes in the state of affairs

There have been no significant changes in the state of affairs of the Group during the year.

Events since the end of the financial year

No other matters or circumstances have arisen since June 30, 2025 that have significantly affected the Group’s operations, results or state of affairs, or may do so in future years.

Likely developments and expected results of operations

The likely developments in our operations, to the extent that such matters can be commented upon, are covered in Item 5A of this report.

Environmental regulation

We are involved in scientific research and development, and the activities do not create any significant environmental impact to any material extent. Our scientific research activities are in full compliance with all prescribed environmental regulations.

B.   Liquidity and Capital Resources
------------------------------------

We are a development stage company, have had no sales income to date and as of June 30, 2025, our accumulated deficit totaled A$225,888,680. We had A$33,158,642 of cash and cash equivalents, and A$7,500,000 in longer dated term deposits as of June 30, 2025, compared to A$12,638,885 as of June 30, 2024.

From inception until our initial public offering in March